Recombinant human serum albumin (OsrHSA) has emerged as a substantial innovation in the sphere of biopharmaceuticals, offering promising breakthroughs across different clinical and industrial programs. With its structural similarity to In a natural way derived human serum albumin, OsrHSA presents a